Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Withdrawn 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Non-Squamous Non-Small Cell Lung Cancer 2Neoplasms 2Head and Neck Neoplasms 1Colorectal Neoplasms 1Carcinoma 1

Interventions

Erlotinib Hydrochloride 21Bevacizumab 13Cisplatin 12Carboplatin 7Pemetrexed 6Gemcitabine 6Paclitaxel 5onartuzumab 4Docetaxel 3imgatuzumab 2sintilimab 1parsatuzumab 1lifastuzumab vedotin 1atezolizumab 1Vinorelbine 1RG-1507 monoclonal antibody 1Platinum Compounds 1Etoposide 12-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine 12,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
INDUSTRY × Non-Squamous Non-Small Cell Lung Cancer × imgatuzumab × Clear all
NCT01702714 2016-11-04

A Study of RO5083945 in Combination With Cisplatin and Gemcitabine or Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer of Squamous Histology Who Have Not Received Prior Chemotherapy for The Metastatic Disease

Hoffmann-La Roche

Phase 1 Withdrawn
Thoracic

Non-Squamous Non-Small Cell Lung Cancer

NCT01185847 2016-01-01

A Study of RO5083945 in Combination With Chemotherapy Versus Chemotherapy Alone in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer

Hoffmann-La Roche

Phase 2 Completed
90 enrolled
Thoracic

Non-Squamous Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡